Urolithiasis: Oxalate Interactions With Renal Cells
Urolithiasis: Oxalate Interactions With Renal Cells
批准号:
7013673
负责人:
HARI K KOUL
金额:
$29.78万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-20 至 2008-01-31
关键词:
JUN kinaseapoptosisbinding proteinsbiological signal transductioncell morphologycytotoxicitydisease /disorder modelenzyme activitygene expressionguanine nucleotide binding proteinimmunoprecipitationintermolecular interactionisozymeskidney celllaboratory ratmitogen activated protein kinasemonoclonal antibodynorthern blottingsnucleic acid biosynthesisoxalatesprimary hyperoxaluriasprotein protein interactionprotein structure functiontransfectionurinary calculiwestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Urolithiasis is a multi-factorial disease and it is unlikely that a single factor will be responsible for the entire spectrum of this disorder. Nonetheless, one important factor is an abnormality in the oxalate metabolism. The manner by which increase in urinary oxalate influences stone formation is not completely understood and has been the focus of our investigation. We have demonstrated that oxalate exposure to renal epithelial cells, results in re-initiation of the DNA synthesis, altered gene expression and cell death, and- promotes crystal retention. However, the specific signal transduction pathways involved in these diverse effects of oxalate are not understood. The proposed studies will evaluate the hypothesis that p38 Mitogen-activated Protein kinase (p38 MAPK) and Jun N-terminal kinase (JNK) signal transduction pathways play a central role in mediating the toxic effects of oxalate and in modulating the cellular responses to oxalate toxicity. This hypothesis is driven by our observations that oxalate exposure selectively caused a rapid and robust activation of p38 MAPK and a mild activation of JNK but had no effect on ERK1/ERK2 MAP kinase pathway. Moreover, the precise sequence/s through which oxalate causes selective activation of p38 MAPK and JNK pathways is/are not understood. The present studies have three objectives: (1) to elucidate the molecular mechanisms involved in oxalate induced activation of p38 Mitogen-activated Protein kinase and Jun N-terminal kinase pathways; (2) to investigate the roles played by p38 Mitogen-activated Protein kinase pathway and Jun N-terminal kinase pathway in mediating the effects of oxalate; and (3) to evaluate the activation of p38 Mitogen-activated Protein kinase and Jun N-terminal kinase pathways, in vivo, in response to hyperoxaluria. Understanding the specific signaling processes that mediate the effects of oxalate in renal epithelial cells will help us develop strategies to inhibit the toxic effects of oxalate and prevent crystal retention and renal stone formation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of PDEF in Prostate Cancer
-
批准号:10385704
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:HARI K KOUL
-
依托单位:
The Role of PDEF in Prostate Cancer
-
批准号:10697300
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:HARI K KOUL
-
依托单位:
Prostate Cancer Health Disparity: Role of PDEF
-
批准号:10223894
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2020
-
负责人:HARI K KOUL
-
依托单位:
Prostate Cancer Health Disparity: Role of PDEF
-
批准号:10689652
-
项目类别:
-
资助金额:$32.95万
-
财政年份:2020
-
负责人:HARI K KOUL
-
依托单位:
Prostate Cancer Health Disparity: Role of PDEF
-
批准号:10165289
-
项目类别:
-
资助金额:$33.63万
-
财政年份:2020
-
负责人:HARI K KOUL
-
依托单位:
Prostate Cancer: Targeting Androgen Receptor Signaling by Tetrandrine
-
批准号:8305421
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Tetrandrine for the treatment of Prostate Cancer
-
批准号:8513803
-
项目类别:
-
资助金额:$1.56万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Tetrandrine for the treatment of Prostate Cancer
-
批准号:8179522
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Prostate Cancer: Targeting Androgen Receptor Signaling by Tetrandrine
-
批准号:8142602
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Tetrandrine for the treatment of Prostate Cancer
-
批准号:8783637
-
项目类别:
-
资助金额:$28.28万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Tetrandrine for the treatment of Prostate Cancer
-
批准号:8902030
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Prostate Cancer: Targeting Androgen Receptor Signaling by Tetrandrine
-
批准号:8698272
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Tetrandrine for the treatment of Prostate Cancer
-
批准号:8704729
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Prostate Cancer: Targeting Androgen Receptor Signaling by Tetrandrine
-
批准号:8402116
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:HARI K KOUL
-
依托单位:
Urolithiasis: Oxalate Interactions with the Renal Cells
-
批准号:7983885
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2009
-
负责人:HARI K KOUL
-
依托单位:
UROLITHIASIS--OXALATE INTERACTIONS WITH RENAL CELLS
-
批准号:2906244
-
项目类别:
-
资助金额:$14.0万
-
财政年份:1997
-
负责人:HARI K KOUL
-
依托单位:
Urolithiasis: Oxalate Interactions With Renal Cells
-
批准号:6572147
-
项目类别:
-
资助金额:$12.38万
-
财政年份:1997
-
负责人:HARI K KOUL
-
依托单位:
Urolithiasis: Oxalate Interactions with the Renal Cells
-
批准号:7667464
-
项目类别:
-
资助金额:$32.73万
-
财政年份:1997
-
负责人:HARI K KOUL
-
依托单位:
UROLITHIASIS--OXALATE INTERACTIONS WITH RENAL CELLS
-
批准号:6381163
-
项目类别:
-
资助金额:$14.67万
-
财政年份:1997
-
负责人:HARI K KOUL
-
依托单位:
Urolithiasis: Oxalate Interactions with the Renal Cells
-
批准号:8134259
-
项目类别:
-
资助金额:$32.07万
-
财政年份:1997
-
负责人:HARI K KOUL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: